• Alphabet: BNP Paribas cut the recommendation to neutral from outperform. PT up 3.8% to $118.
  • Amazon: Jefferies gives a buy rating. Target price is lowered from USD 163 to USD 150.
  • Chevron: HSBC gives a buy rating. PT up 15% to $167.
  • Datadog: Bernstein starts at outperform with $172 price target.
  • Eagle Materials: J.P. Morgan decreases to neutral from overweight. PT set to $130.
  • Equity Residential: Piper Sandler decreased to underweight from neutral. PT up 3.5% to $70.
  • FMC Corp: KeyBanc Capital Markets raised the recommendation to overweight from sector weight. PT up 18% to $122.
  • Incyte Corporation: Goldman Sachs adjusts price target to $127 from $124 Maintains buy rating.
  • Marathon Petroleum: Goldman Sachs reiterates neutral rating. PT up to $99 from $98.
  • Micro Focus International: Goldman Sachs cuts to sell from buy. PT down 11% to 255 pence.
  • Netflix: Jefferies gives a neutral rating. Target price is lowered from USD 280 to USD 243.
  • Range Ressources Corporation: BofA Securities maintains buy rating. PT ugraded to $49 from $37.
  • Rio Tinto: Goldman Sachs maintains a buy rating. PT is lowered from GBX 5700 to GBX 5680.
  • Sage Group: Goldman Sachs upgrades to neutral from sell. PT set to 670 pence.
  • Sea Limited: Barclays adjusts price target to $125 from $157. Maintains overweight rating.
  • Schroders: Goldman Sachs initiated coverage with a recommendation of sell. PT set to 2.530 pence.
  • Synchrony Financial: J.P. Morgan maintains neutral rating and price target upgrades to $41 from $39.
  • Tenet Healthcare: Wolfe lowers price target to $58 from $82, it maintains perform rating.
  • Ultragenyx Pharmaceutical: Goldman Sachs adjusts price target to $75 from $101. Maintains neutral rating.
  • Woodward: Truist Securities maintains a buy rating. PT up 34% from last price.